• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

偶发性前列腺癌的发病率和死亡率：一项基于瑞典登记处的研究。

Incidence and mortality of incidental prostate cancer: a Swedish register-based study.

作者信息

Andrèn O, Garmo H, Mucci L, Andersson S-O, Johansson J-E, Fall K

机构信息

Department of Urology Orebro University Hospital, Orebro 701 85, Sweden.

出版信息

Br J Cancer. 2009 Jan 13;100(1):170-3. doi: 10.1038/sj.bjc.6604834. Epub 2008 Dec 16.

DOI:10.1038/sj.bjc.6604834
PMID:19088721
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2634678/
Abstract

In a national register-based study of incidence trends and mortality of incidental prostate cancer in Sweden, we found that a significant proportion (26.6%) of affected men diagnosed died of their disease, which challenges earlier descriptions of incidental prostate cancer as a non-lethal disease.

摘要

在一项基于瑞典国家登记册的关于偶发性前列腺癌发病率趋势和死亡率的研究中，我们发现，确诊的患病男性中有很大一部分（26.6%）死于该疾病，这对早期将偶发性前列腺癌描述为非致命性疾病的观点提出了挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/2634678/42d36397ef49/6604834f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/2634678/5e849e4d5b4f/6604834f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/2634678/42d36397ef49/6604834f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/2634678/5e849e4d5b4f/6604834f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376c/2634678/42d36397ef49/6604834f2.jpg

相似文献

1
Incidence and mortality of incidental prostate cancer: a Swedish register-based study.偶发性前列腺癌的发病率和死亡率：一项基于瑞典登记处的研究。
Br J Cancer. 2009 Jan 13;100(1):170-3. doi: 10.1038/sj.bjc.6604834. Epub 2008 Dec 16.
2
Capture rate and representativity of The National Prostate Cancer Register of Sweden.瑞典国家前列腺癌登记处的捕获率和代表性。
Acta Oncol. 2015 Feb;54(2):158-63. doi: 10.3109/0284186X.2014.939299. Epub 2014 Jul 18.
3
Prostate carcinoma trends in three counties in Sweden 1987-1996: results from a population-based national cancer register. South-East Region Prostate Cancer Group.1987 - 1996年瑞典三个县的前列腺癌发病趋势：基于全国人口癌症登记处的结果。东南地区前列腺癌研究小组。
Cancer. 2000 Mar 15;88(6):1445-53. doi: 10.1002/(sici)1097-0142(20000315)88:6<1445::aid-cncr24>3.0.co;2-t.
4
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.在无疾病临床症状的男性中通过前列腺特异性抗原检测诊断出的前列腺癌：一项基于瑞典国家前列腺癌登记处数据的人群研究
Scand J Urol Nephrol. 2010 Dec;44(6):384-90. doi: 10.3109/00365599.2010.498793. Epub 2010 Jul 13.
5
A comparative population-based study of prostate cancer incidence and mortality rates in Singapore, Sweden and Geneva, Switzerland from 1973 to 2006.一项基于人群的比较研究，对 1973 年至 2006 年新加坡、瑞典和瑞士日内瓦的前列腺癌发病率和死亡率进行了研究。
BMC Cancer. 2012 Jun 6;12:222. doi: 10.1186/1471-2407-12-222.
6
Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease.神经内分泌信号通路在局部诊断前列腺癌男性的致命性和非致命性前列腺癌中的表达和遗传变异。
Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1781-1787. doi: 10.1158/1055-9965.EPI-17-0453. Epub 2017 Sep 22.
7
Familial prostate cancer in Sweden. A nationwide register cohort study.瑞典的家族性前列腺癌。一项全国性登记队列研究。
Cancer. 1996 Jan 1;77(1):138-43. doi: 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5.
8
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.解读北欧五国前列腺癌发病率和死亡率的趋势。
J Natl Cancer Inst. 2007 Dec 19;99(24):1881-7. doi: 10.1093/jnci/djm249. Epub 2007 Dec 11.
9
Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden.家族性前列腺癌及可能相关的恶性肿瘤：瑞典全国性登记队列研究
Int J Cancer. 1998 Oct 29;78(3):293-7. doi: 10.1002/(SICI)1097-0215(19981029)78:3<293::AID-IJC5>3.0.CO;2-Q.
10
Differences in survival from prostate cancer in Denmark, Iceland and Sweden.丹麦、冰岛和瑞典前列腺癌患者生存率的差异。
Eur J Cancer. 2013 May;49(8):1984-92. doi: 10.1016/j.ejca.2013.01.008. Epub 2013 Mar 1.

引用本文的文献

1
Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate.偶然诊断前列腺癌后行钬激光前列腺剜除术后的自然史。
PLoS One. 2023 Feb 2;18(2):e0278931. doi: 10.1371/journal.pone.0278931. eCollection 2023.
2
Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis.某些良性前列腺增生症手术中偶发前列腺癌的患病率及危险因素：系统评价和荟萃分析。
Int Braz J Urol. 2022 Nov-Dec;48(6):915-929. doi: 10.1590/S1677-5538.IBJU.2021.0653.
3
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.

本文引用的文献

1
Reliability of death certificates in prostate cancer patients.前列腺癌患者死亡证明的可靠性。
Scand J Urol Nephrol. 2008;42(4):352-7. doi: 10.1080/00365590802078583.
2
The management of category T1a-T1b (incidental) prostate cancer: can we predict who needs treatment?T1a-T1b期（偶然发现）前列腺癌的管理：我们能否预测谁需要治疗？
Eur Urol. 2008 Jul;54(1):16-8. doi: 10.1016/j.eururo.2008.03.099. Epub 2008 Mar 28.
3
Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors.
主动监测前列腺癌：偶发肿瘤与前列腺穿刺活检诊断肿瘤的比较。
World J Urol. 2022 Feb;40(2):443-451. doi: 10.1007/s00345-021-03864-6. Epub 2021 Oct 23.
4
Incidental Prostate Cancer in Patients Treated for Benign Prostate Hyperplasia in the Period of 21 Years.21年间接受良性前列腺增生治疗患者中的偶发性前列腺癌
Acta Clin Croat. 2018 Oct;57(Suppl 1):71-76. doi: 10.20471/acc.2018.57.s1.11.
5
Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist?前列腺增生症患者手术治疗期间获取的所有标本都应由病理学家进行评估吗？
Cent European J Urol. 2014;67(3):227-32. doi: 10.5173/ceju.2014.03.art2. Epub 2014 Aug 18.
6
What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?对于因其他恶性肿瘤接受PET/CT检查的患者，前列腺中氟代脱氧葡萄糖（FDG）意外摄取的临床意义是什么？
Int J Mol Imaging. 2013;2013:476786. doi: 10.1155/2013/476786. Epub 2013 Dec 28.
7
Clinical experiences of incidental prostate cancer after transurethral resection of prostate (TURP) according to initial treatment: a study of a Korean high volume center.根据初始治疗的经尿道前列腺切除术（TURP）后偶然发现的前列腺癌的临床经验：韩国大容量中心的一项研究。
Yonsei Med J. 2014 Jan;55(1):78-83. doi: 10.3349/ymj.2014.55.1.78.
8
Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.良性前列腺增生组织消融手术时代偶然发现前列腺癌诊断的术前临床因素：一项韩国多中心综述
Korean J Urol. 2012 Jun;53(6):391-5. doi: 10.4111/kju.2012.53.6.391. Epub 2012 Jun 19.
9
Trends in prostate cancer survival in Spain: results from population-based cancer registries.西班牙前列腺癌生存趋势：基于人群的癌症登记处的结果。
Clin Transl Oncol. 2012 Jun;14(6):458-64. doi: 10.1007/s12094-012-0824-0.
10
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.通过量化前列腺切除标本中的基质癌区域来确定前列腺癌特异性死亡。
Am J Pathol. 2011 Jan;178(1):79-87. doi: 10.1016/j.ajpath.2010.09.042. Epub 2010 Dec 23.
Scand J Urol Nephrol. 2007;41(2):103-9. doi: 10.1080/00365590600991268.
4
Long-term outcome among men with conservatively treated localised prostate cancer.接受保守治疗的局限性前列腺癌男性患者的长期预后。
Br J Cancer. 2006 Nov 6;95(9):1186-94. doi: 10.1038/sj.bjc.6603411.
5
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.局限性前列腺癌的区域起源不影响根治性前列腺切除术后的生化复发率。
Eur Urol. 2007 Apr;51(4):949-55; discussion 955. doi: 10.1016/j.eururo.2006.07.008. Epub 2006 Jul 28.
6
How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden.Gleason评分对前列腺癌死亡的预测效果如何？瑞典一项基于人群队列的20年随访研究。
J Urol. 2006 Apr;175(4):1337-40. doi: 10.1016/S0022-5347(05)00734-2.
7
20-year outcomes following conservative management of clinically localized prostate cancer.临床局限性前列腺癌保守治疗后的20年随访结果
JAMA. 2005 May 4;293(17):2095-101. doi: 10.1001/jama.293.17.2095.
8
Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening.在引入前列腺特异性抗原筛查前后收集的经尿道前列腺切除术标本中的偶发性前列腺腺癌及假定的癌前病变。
Arch Pathol Lab Med. 2000 Oct;124(10):1454-6. doi: 10.5858/2000-124-1454-IPAAPP.
9
Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications.因不可触及病变而行前列腺癌根治术标本中的小的高级别前列腺腺癌：发病机制及临床意义
J Urol. 1994 Jun;151(6):1587-92. doi: 10.1016/s0022-5347(17)35309-0.
10
The pathology of incidental carcinoma.偶发性癌的病理学
Cancer Surv. 1995;23:7-18.